Vanta Bioscience (540729.BO) Stock Price

Vanta Bioscience Price

CLOSED
20.42
​
Market closed

Revenue at Vanta Bioscience has contracted by 9.6% per year over the past 7 years to 19.64 M INR. Earnings per share have grown at 29.3% per year over the last 4 years. For Vanta Bioscience, the net margin of -243.2% is down versus 4.5% a few years ago.

Vanta Bioscience stock price

Access this data via the Eulerpool API

Vanta Bioscience business model & stock analysis

Vanta Bioscience Ltd. engages in the full service preclinical contract research organization. The company is headquartered in Secunderabad, Telangana. The company went IPO on 2017-10-06. The firm is providing services of testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research and environmental studies. The company offers a host of preclinical safety assessment services for clientele from pharmaceutical, medical devices, nutraceuticals, feed additive, biotech, agrochemicals, cosmetics, and chemical industries. In addition, it also provides risk assessment services for evaluating the safety of the active pharmaceutical ingredients (API), excipients, extractable and leachable, including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. The company also provides services for determination of health-based exposure limits, such as permitted daily exposure (PDE) or allowable daily exposure (ADE), including occupational exposure limits (OEL) for pharmaceutical manufacturers.

Frequently asked questions about Vanta Bioscience

Converted at the current exchange rate, the Vanta Bioscience share trades at 0.19 EUR (20.42 INR).

The revenue cannot currently be calculated for Vanta Bioscience.

The profit cannot currently be calculated for Vanta Bioscience.

The P/E ratio cannot be calculated for Vanta Bioscience at the moment.

The P/S cannot be calculated for Vanta Bioscience currently.

The Eulerpool Quality Score for Vanta Bioscience is 1/10.

The ISIN of Vanta Bioscience is INE695X01011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Vanta Bioscience is 540729.BO. The ticker symbol is used to trade Vanta Bioscience shares on the stock exchange.

Fair ValueTerminal
16.74 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Life Sciences Tools & Services
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website vantabio.com
Country
Currency
INR
Initial public offering
Oct 6, 2017
ISIN
INE695X01011
Cusip
Y93560103
Market capitalization
145.19 M INRMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
1.39
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5.93 %
Last updated Oct 11, 2026, 8:08 PM

Vanta Bioscience Peer Group

Vanta Bioscience FIGI

VANTA:IN · BBG00HPJMGW8VANTA:IB · BBG00HPJMGX7

All fundamentals and in-depth analysis of Vanta Bioscience

Our stock analysis for Vanta Bioscience stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vanta Bioscience. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.